GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (LTS:0I0L) » Definitions » Revenue

Labo Euromedis (LTS:0I0L) Revenue : €34.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Labo Euromedis Revenue?

Labo Euromedis's revenue for the six months ended in Jun. 2023 was €24.69 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €34.00 Mil. Labo Euromedis's Revenue per Share for the six months ended in Jun. 2023 was €8.44. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €11.71.

Warning Sign:

Labo Euromedis revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Labo Euromedis was -26.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -16.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 14 years, Labo Euromedis's highest 3-Year average Revenue per Share Growth Rate was 30.20% per year. The lowest was -16.30% per year. And the median was 0.90% per year.


Labo Euromedis Revenue Historical Data

The historical data trend for Labo Euromedis's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis Revenue Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.08 193.41 111.90 54.18 34.00

Labo Euromedis Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.99 29.33 24.86 24.69 9.31

Competitive Comparison of Labo Euromedis's Revenue

For the Medical Devices subindustry, Labo Euromedis's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labo Euromedis's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's Revenue distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's Revenue falls into.



Labo Euromedis Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €34.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis  (LTS:0I0L) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Labo Euromedis Revenue Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis (LTS:0I0L) Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (LTS:0I0L) Headlines

No Headlines